In contrast, other reports demonstrated the opposite results, such as decreased membrane-bound DPP4 activity in RCC and correlation of high soluble DPP4 activity (measured in tumor tissue homogenates) with tumor aggressiveness [61] and poor survival of RCC patients [62]. The gene discussed is DPP4; the disease is renal cell carcinoma.